In the analysis for OS, all four scales selected for further analysis had prognostic value for OS after adjusting for IPI alone (Figure 1A), and after adjusting for IPI and other key variables (cell of origin, BCL2 mutation status, and total metabolic tumor volume) in addition to IPI (Figure 1B). This evidence concerns the gene BCL2 and neoplasm.